Signal detection and safety analysis of three tyrosine kinase inhibitors for HER-2 positive breast cancer: a retrospective study based on the FAERS database

ObjectiveTo identify adverse event (ADE) signals of three tyrosine kinase inhibitors (TKIs) (Tucatinib, Lapatinib, and Neratinib) used for HER-2 positive breast cancer by utilizing the FAERS database, and to analyze their safety profiles to provide references for clinical risk management.MethodsData...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Xiting Tang, Chengliang Wang, Yanwei Li, Jing Tang, Guoping Zhang, Li Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1538881/full